Related references
Note: Only part of the references are listed.Suppression of autophagy permits successful enzyme replacement therapy in a lysosomal storage disorder-murine Pompe disease
Nina Raben et al.
AUTOPHAGY (2010)
Autophagy inhibition induces atrophy and myopathy in adult skeletal muscles
Eva Masiero et al.
AUTOPHAGY (2010)
Fighting disease by selective autophagy of aggregate-prone proteins
Helene Knaevelsrud et al.
FEBS LETTERS (2010)
Peroxisome Proliferator-activated Receptor γ Coactivator 1α or 1β Overexpression Inhibits Muscle Protein Degradation, Induction of Ubiquitin Ligases, and Disuse Atrophy
Jeffrey J. Brault et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial
S. Strothotte et al.
JOURNAL OF NEUROLOGY (2010)
A Randomized Study of Alglucosidase Alfa in Late-Onset Pompe's Disease.
Ans T. van der Ploeg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Regulation Mechanisms and Signaling Pathways of Autophagy
Congcong He et al.
ANNUAL REVIEW OF GENETICS (2009)
When more is less Excess and deficiency of autophagy coexist in skeletal muscle in Pompe disease
Nina Raben et al.
AUTOPHAGY (2009)
Autophagy Is Required to Maintain Muscle Mass
Eva Masiero et al.
CELL METABOLISM (2009)
A Family of microRNAs Encoded by Myosin Genes Governs Myosin Expression and Muscle Performance
Eva van Rooij et al.
DEVELOPMENTAL CELL (2009)
Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease
Marc Nicolino et al.
GENETICS IN MEDICINE (2009)
PPARγ activation induces autophagy in breast cancer cells
Jie Zhou et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
PRECLINICAL DRUG TRIALS IN THE mdx MOUSE: ASSESSMENT OF RELIABLE AND SENSITIVE OUTCOME MEASURES
Christopher F. Spurney et al.
MUSCLE & NERVE (2009)
被撤回的出版物: Increased muscle PGC-1 alpha expression protects from sarcopenia and metabolic disease during aging(Retracted article. See vol.113,pg.E8502,2016)
Tina Wenz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The role of autophagy in neonatal tissues - Just a response to amino acid starvation?
Stefano Schiaffino et al.
AUTOPHAGY (2008)
PGC-1 coactivators and skeletal muscle adaptations in health and disease
Zolt Arany
CURRENT OPINION IN GENETICS & DEVELOPMENT (2008)
Modulation of glycogen synthesis by RNA interference: towards a new therapeutic approach for glycogenosis type II
Gaelle Douillard-Guilloux et al.
HUMAN MOLECULAR GENETICS (2008)
Suppression of autophagy in skeletal muscle uncovers the accumulation of ubiquitinated proteins and their potential role in muscle damage in Pompe disease
Nina Raben et al.
HUMAN MOLECULAR GENETICS (2008)
Stimulation of mitochondrial biogenesis and autophagy by lipopolysaccharide in the neonatal rat cardiomyocyte protects against programmed cell death
Diane L. M. Hickson-Bick et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2008)
Autophagy fights disease through cellular self-digestion
Noboru Mizushima et al.
NATURE (2008)
BNIP3 subfamily BH3-only proteins: mitochondrial stress sensors in normal and pathological functions
G. Chinnadurai et al.
ONCOGENE (2008)
Paradoxical effects of increased expression of PGC-1α on muscle mitochondrial function and insulin-stimulated muscle glucose metabolism
Cheol Soo Choi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Modest PGC-1α overexpression in muscle in vivo is sufficient to increase insulin sensitivity and palmitate oxidation in subsarcolemmal, not intermyofibrillar, mitochondria
Carley R. Benton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
A rational mechanism for combination treatment of Huntington's disease using lithium and rapamycin
Sovan Sarkar et al.
HUMAN MOLECULAR GENETICS (2008)
A role for the transcriptional coactivator PGC-1α in muscle refueling
Adam R. Wende et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Deconstructing Pompe disease by analyzing single muscle fibers
Nina Raben et al.
AUTOPHAGY (2007)
Skeletal muscle fiber-type switching, exercise intolerance, and myopathy in PGC-1α muscle-specific knock-out animals
Christoph Handschin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Activity-dependent signaling pathways controlling muscle diversity and plasticity
Stefano Schiaffino et al.
PHYSIOLOGY (2007)
Differential muscular glycogen clearance after enzyme replacement therapy in a mouse model of Pompe disease
Michael L. Hawes et al.
MOLECULAR GENETICS AND METABOLISM (2007)
Recombinant human acid α-glucosidase -: Major clinical benefits in infantile-onset Pompe disease
P. S. Kishnani et al.
NEUROLOGY (2007)
Acid alpha-glucosidase deficiency (Pompe disease)
Tokiko Fukuda et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2007)
Characterization of pre- and post-treatment pathology after enzyme replacement therapy for pompe disease
Beth L. Thurberg et al.
LABORATORY INVESTIGATION (2006)
Peroxisome proliferator-activated receptor γ coactivator 1 coactivators, energy hemeostasis, and metabolism
Christoph Handschin et al.
ENDOCRINE REVIEWS (2006)
Autophagy and mistargeting of therapeutic enzyme in skeletal muscle in Pompe disease
Tokiko Fukuda et al.
MOLECULAR THERAPY (2006)
PGC-1α a protects skeletal muscle from atrophy by suppressing Fox03 action and atrophy-specific gene transcription
Marco Sandri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Overexpression of peroxisome proliferator-activated receptor γ co-activator-1α leads to muscle atrophy with depletion of ATP
Shinji Miura et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease
Priya S. Kishnani et al.
JOURNAL OF PEDIATRICS (2006)
PGC-1 coactivators: inducible regulators of energy metabolism in health and disease
BN Finck et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Endurance training increases skeletal muscle LKB1 and PGC-1α protein abundance:: effects of time and intensity
EB Taylor et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
The natural course of non-classic Pompe's disease; a review of 225 published cases
LPF Winkel et al.
JOURNAL OF NEUROLOGY (2005)
Replacing acid alpha-glucosidase in Pompe disease: Recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers
N Raben et al.
MOLECULAR THERAPY (2005)
Glycogen autophagy
OB Kotoulas et al.
MICROSCOPY RESEARCH AND TECHNIQUE (2004)
LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation
Y Kabeya et al.
JOURNAL OF CELL SCIENCE (2004)
Overexpression of peroxisome proliferator-activated receptor γ coactivator-1α down-regulates GLUT4 mRNA in skeletal muscles
S Miura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature
HMP van den Hout et al.
PEDIATRICS (2003)
Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres
J Lin et al.
NATURE (2002)
Beclin-phosphatidylinositol 3-kinase complex functions at the trans-Golgi network
A Kihara et al.
EMBO REPORTS (2001)
Restoration of insulin-sensitive glucose transporter (GLUT4) gene expression in muscle cells by the transcriptional coactivator PGC-1
LF Michael et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
